7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) – Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Meeting
Le Palais des Congres de ParisParis, FRANCE Visit the Venue to read more
Dear colleagues and friends
On behalf of ECTRIMS and ACTRIMS Executive Committees, it is our pleasure to welcome you to Paris on the occasion of the 7th Joint ECTRIMS-ACTRIMS Meeting from 25 to 28 October 2017.
Paris is the city of Jean Martin Charcot who identified and named multiple sclerosis, in his famous Salpêtrière lecture of 1868. It is a very active city for neurology and neurosciences, with a highly dynamic Parisian multiple sclerosis network bridging clinical, imaging, genetics, immunology and neurobiology fields.
With assistance from the Local Organising Committee, composed of colleagues from Paris and French regions, we have done our best to set up an attractive programme which covers novel developments in the multiple sclerosis field, from the bench to the bedside. The programme will offer teaching courses, plenary lectures, free communications selected from abstracts, and hot topic, young investigator and poster sessions.
Themes will include recent advances in neurobiology and neuro-immunology, new diagnostic criteria, multiple sclerosis biomarkers, multiple sclerosis management and insight into multiple sclerosis borders, clinical trials results and emerging strategies to promote repair. In addition, there will be a special section of the programme for MS nurses and symposia sponsored by the European Charcot Foundation and industry.
The meeting will take place in the “Palais des Congrès”, a strategic location in Paris and one of the world‘s most significant conference centres with a wide range of nearby hotel accommodation.
Aside from neurology and neurosciences, Paris is well known for fashion, culture, food and entertainment. It benefits from a very convenient metro and bus public transportation system, but do not hesitate to rent the Velib bikes to discover the whole city, enjoy the banks of the Seine and all the Parisian jewels. Also take time to have a drink in the many Parisian cafés.
Victor Hugo said that “Respirer Paris, cela conserve l’âme”, that you can translate as “Breathing Paris keeps your soul”, and Hemingway wrote “A moveable feast”, translated in French as “Paris est une fête”. As all the Parisians who love their beautiful city, we are convinced that this meeting will not only be scientifically exciting but also that you will fall in love with Paris.
We look forward to welcoming you to Paris for MSParis2017!
ECTRIMS Vice President
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Palais des congres de Paris
2 Place de la Porte Maillot
Paris, Ile-de-France, France
Abstracts may only be submitted online. Abstracts submitted by fax or email will not be accepted.
Abstracts must be submitted in English. Please use UK English spelling.
The presenting author of an accepted abstract must register and attend the congress.
Poster presenters must be present and stand by their posters during their assigned poster sessions.
Abstracts should contain only original material not published or presented elsewhere prior to 25 October 2017.
Provide a short specific title indicating the nature of the investigation. The background and goals of the study should appear clearly to the reader. The methods and results must contain data, and the conclusions should be clearly expressed.
The abstract text may not be longer than 2500 characters including spaces (ca. 300 words).
All abbreviations must be defined the first time they appear in your text (but, do not define in the title).
Example: Multiple Sclerosis Impact Scale (MSIS), before being used as an abbreviation only.
Use generic drug names.
Tables, charts or other graphics may not be included and will be deleted by the editors.
Authors should indicate their presentation preference:
- poster presentation only
- oral or poster presentation
Note: "Poster presentation only" implies that your abstract will be considered for poster presentation only and will not be eligible for the poster prize (see corresponding paragraph Prizes).
The Scientific Programme Committee reserves the right to decide on the final allocation and presentation method.
A selected number of abstracts will be accepted for oral presentation based on their scientific merits and on their relation to the topic addressed in the scientific programme of the Congress. We therefore encourage submission on the main topics covered in the scientific programme.
Disclosure of conflict of interest (e.g. grant support, consultancy, membership on advisory councils, speaker’s bureau) by all authors and source of funding are mandatory. Each listed author should prepare a one sentence statement to this effect.
Abstracts from commercial entities will be considered. However, abstracts reporting results from collaborative research conducted by independent (non-company) investigators and investigators who are employees of commercial entities will not be accepted unless the independent (academic, clinician and/or scientist) investigators are included as authors.
Please make sure to state your correct e-mail address. After having submitted your abstract, you will receive a confirmation by e-mail with the following information:
reference number of your abstract (for correspondence and questions that might arise)
your personal user code and password.
If you do not receive a confirmation by e-mail please contact msparis2017[at]abstractserver.com
Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access codes. This will shorten the submission procedure.
Corrections to abstracts can only be made up to the deadline of 31 May 2017.
We kindly ask you to upload a picture of the presenting author. Please prepare the photo in one of the following formats: JPG, GIF or PNG, with a max. size of 1 MB.
Contact No.: +41 61 686 77 77